This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Corcept Therapeutics Inc (CORT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 54.88M 93.03M 39.64M 24.58M
Receivables 1.43M 557.00K 0.00 0.00
Inventories 1.10M 853.00K 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 58.31M 95.06M 39.78M 25.00M
Property, Plant & Equipment, Gross 351.00K 227.00K 76.00K 51.00K
Accumulated Depreciation & Depletion 148.00K 77.00K 50.00K 47.00K
Property, Plant & Equipment, Net 203.00K 150.00K 26.00K 4.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 4.56M 3.95M 32.00K 104.00K
Total Non-Current Assets 4.77M 4.10M 58.00K 108.00K
Liabilities & Shareholder Equity
Total Assets 63.08M 99.17M 39.83M 25.10M
Accounts Payable 2.38M 3.80M 3.61M 817.00K
Short Term Debt 5.74M 2.65M 0.00 0.00
Other Current Liabilities 0.00 0.00 533.00K 422.00K
Total Current Liabilities 12.74M 8.36M 5.03M 3.86M
Long Term Debt 29.32M 29.03M 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 29.32M 29.03M 0.00 0.00
Total Liabilities 42.06M 37.39M 5.03M 3.86M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 21.02M 61.78M 34.81M 21.24M
Common Par 100.00K 100.00K 84.00K 72.00K
Additional Paid In Capital 313.53M 308.28M 243.28M 197.47M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -292.62M -246.61M -208.56M -176.20M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 -97.00K
Total Capitalization 50.34M 90.81M 34.81M 21.24M
Total Equity 21.02M 61.78M 34.81M 21.24M
Total Liabilities & Stock Equity 63.08M 99.17M 39.83M 25.10M
Total Common Shares Outstanding 99.85M 99.81M 84.23M 72.40M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 99.82M 93.02M 83.31M 68.34M
Diluted Weighted Shares Outstanding 99.82M 93.02M 83.31M 68.34M
Number of Employees 44 17 31 31
Number of Part-Time Employees 6 5 5 4
CORT News

CORT Corcept Therapeutics Inc

Analysts Ratings for CORT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 2 2 4 4
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET CORT ANALYST REPORT

Brokerage Partners

CORT Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs